Table 4.

Univariate and Multivariate Analysis on Overall Survival

N:250	Log-rank*	HR	95% CI	p	HR	95% CI	p
Gender	0.606	0.909	0.630–1.311	0.610
Age70	0.102	1.369	0.934–2.006	0.107	0.685	0.457–1.027	0.067
Neoadjuvant	0.164	1.338	0.883–2028	0.170
Comorbidity	0.208	1.263	0.874–1.826	0.213
Pre-Operative Hb		0.990	0.914–1.074	0.814
Difference in Hb		1.185	1.052–1.334	0.005	1.121	0.991–1.269	0.070
Albumin		0.753	0.511–1.108	0.150
Stage T (T1-T2 vs. T3-T4)	< 0.001	4.371	2.133–8.957	< 0.001	0.356	0.149–0.851	0.020
Stage N (N0 vs. N+)	0.005	1.862	1.192–2.909	0.006	1.145	0.634–2.068	0.643
Lymphovascular Invasion	0.001	1.588	1.191–2.117	0.002	1.749	0.757–4.043	0.191
Adjacent Organ Invasion	< 0.001	0.383	0.238–0.615	< 0.001	1.836	1.066–3.161	0.028
Peritoneal Cytology(+) (N:139)	0.115	0.666	0.405–1.096	0.110
Complication	0.131	0.726	0.477–1.107	0.137

*Log-Rank tesl was performed on the categorical variables.

Hb: Hemoglobin